Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Cells, 2021, 10, 2366. https://doi.org/10.3390/cells10092366 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. X. Xu et al., Nan Fang Yi Ke Da Xue Xue Bao, Apr 2006; 26(4): 398-401 | |||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | |||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Oncotarget, 2016, 7 (28): 43654-43668 | Link | ||
U138 MG |
Human brain glioblastoma cell line | ATCC HTB-16 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | |
U138 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | E. Fuchs, Julius-Maximilians-Universität Würzburg | Link | ||
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. Dietschy et al., J. Cell Sci., Apr 2009; 122: 1258 - 1267 | Link | ||
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. Zheng et al., Nucleic Acids Res., May 2009; 37: 2645 - 2657 | Link | |
TT |
Human medullary thyroid carcinoma cell line | ATCC CRL-1803 | Human | other | cell line | adherent | plasmid | Metafectene | publication | T. Takahashi et al., J. Biochem., Nov 2009; 146: 675 - 682 | |||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
tsa201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | S. Geisler et al., J. of Neuroscience, 2019, 39(14): 2581–2605, 2581, doi.org/10.1523/JNEUROSCI.2234-18.2019 | Link | ||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Rizzi et al., The J. of Comparative Neurology, 2016, 524:2093-2116; DOI 10.1002/cne.23934 | Link | |||
TPC1 |
Human thyroid gland papillary carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | plasmid | RNA-Interference | Metafectene | publication | M.-H. Chien et al., Carcinogenesis, Dec 2009; 30: 2005 - 2013 | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | oligonucleotide | Metafectene | publication | L. Zheng et al., J. Leukoc. Biol., Sep 2007; 82: 619 - 629 | Link |